Search
for
Sort by
Research 511–540 of 1000+
- Mechanism of PPARα agonist in alopecia areata
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Efficacy of therapy with 311nm narrow-band UVB 311nm in the treatment of patients with alopecia areata associated with atopic dermatitis
- Janus Kinase inhibitors in dermatology: a review
- Alopecia universalis treated with simvastatin/ezetimibe, minoxidil, and prednisolone in a 6‐year‐old girl
- Montagna Symposium 2017—Precision Dermatology: Next Generation Prevention, Diagnosis, and Treatment
- 455 Molecular correlation with clinical outcomes in an open label clinical trial of oral tofacitinib in patients with alopecia areata
- Update on Hidradenitis Suppurativa (Part I): Epidemiology, Pathogenesis, Severity assessment and Comorbidities
- Biomaterials for dermal substitutes
- Transplantation of melanocyte stem cells in vitiliginous skin
- Melanocytes and Vitiligo (and Hair Graying)
- DERMATOLOGICAL AND SYSTEMIC REACTIONS TO HAIR DYES: CURRENT EVIDENCE AND MANAGEMENT
- The role of protein lactylation in skin diseases: from molecular mechanisms to potential therapeutics
- Mesenchymal stem cell therapy for skin repair and rejuvenation
- Follicular Atopic Dermatitis in Dark Skin
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- A Comprehensive Systematic Review of the Association Between Vitamin D Deficiency and Alopecia Areata
- Bridging psychoneuroimmunology and homeopathy: Modulating the cellular and emotional cascades in refractory alopecia
- Network pharmacology and in vivo experimental analysis for validating the antifibrotic potential of Punica granatum leaves against skin scleroderma: the role of oxidative stress, inflammation and TGF-β1/Snail 1/p-Smad 3 signaling pathway
- Evidence for murine cutaneous immune surveillance localized to hair follicle epithelium
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- Nanotechnological reprogramming of the pathological skin microenvironment in scar formation and atopic dermatitis
- SPT6 maintains epidermal homeostasis by inhibiting an NF-κB-positive feedback loop to prevent excessive inflammation
- Efficacy and safety of tofacitinib in patients with alopecia areata
- Exploring the therapeutic potential of naturally occurring taxifolin, a dietary flavonoid: an updated comprehensive review
- TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Global, regional, and national burden of alopecia areata in adolescents and young adults aged 10–24 years from 1990 to 2021: a trend analysis
- Amelioration of psoriasis-like skin lesions by human amniotic mesenchymal stem cells: insights from multiomics profiling in mice
- The Role of Janus Kinase Inhibitors in Dermatology